Arkolith/Insider Trading/ACUR/Form 4

Skelly William G

DirectorACURA PHARMACEUTICALS, INC (ACUR) · full profile →Form 4 · filed Jan 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2025Option exercise(M)50K——626K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2025Grant(A)50K——50K
Jan 2, 2025Option exercise(M)50K——0

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-006021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML